💬 Catch @JackCastle, Head of Corporate Development & Business Operations, at @BPatientCap x @CooleyLLP Biotech CEO Event.
He'll share insights from Ochre Bio’s deal-making journey.
🕓 4pm – Arrival
🎤 4:15pm – Deal Spotlight interview
🤝 6pm – Networking
#TeamOchre
MASH affects 1.5-6.45% of the global population.
Great to see our name in this @NatureBiotech article, highlighting how some innovative biotechs are helping uncover the molecular mechanisms underpinning this underserved disease ➡️ https://t.co/kuteFussq8
🚀 Announcing our new multi-year data license agreement with @GSK to investigate the drivers of #liverdisease!
Read the announcement ➡️
https://t.co/KgY2AZVYWI
Screening and disease models in drug R&D generally identify drug candidates then fail to work in people. So @OchreBio had a cunning plan; use real human livers to model real human livers. @Jack_O_Meara
Boehringer announced a new chronic liver disease partnership w/Oxford, UK-based biotech & @ycombinator alum @OchreBio. $35M upfront & near-term payments & up to $1B if milestones met. CEO is @Jack_O_Meara, CSO @QuinWills, @jackcastle is Head of Corporate Development. Congrats!
Super proud of the Ochre and BI teams coming together for this partnership to break ground in an underexplored area of liver biology. Excited about this one! Thanks to BI for welcoming us.
🎉 Announcing our partnership with @Boehringer to develop novel regenerative treatments for chronic #liverdisease, which affects affect millions worldwide!
Together we will continue to pioneer liver regeneration research. Full announcement➡️ https://t.co/nZSQEuk34T
🎉 Announcing our partnership with @Boehringer to develop novel regenerative treatments for chronic #liverdisease, which affects affect millions worldwide!
Together we will continue to pioneer liver regeneration research. Full announcement➡️ https://t.co/nZSQEuk34T
We're featured in the #DecodingBio 2023 Snapshot, highlighting the companies shaping the bio landscape.
Our mission is to redefine liver medicines – through an approach rooted in #genomics & human models.
Check out the report➡️https://t.co/faz2lsKcg0
On the Decoding Life podcast, our Director of In Silico Biology, Dimitris Polychronopoulos shares how advancements in computational #biology are changing the game in #healthcare.
Learn more about how Dimitris is 'cracking life's code' ➡️https://t.co/RxrCvzHCkd
This week, 5-8th June, @Jack_O_Meara & @jackcastle, will be in Boston USA for the BIO International Convention!
They're looking forward to meeting industry leaders, and learning about the breakthroughs & challenges facing the #biotech industry today,
Connect with us ⬇️
We are pleased to announce the appointment of Dr @EliotForster as Chairperson of our Board of Directors 🎉
"We look forward to leveraging his extensive leadership experience towards the development of impactful medicines for #liverdisease patients”
➡️https://t.co/xATBJCGsIX
Catch us onstage at the @LSXLeaders World Congress!
🔸May 3rd, 10.45 – @jackcastle will be discussing our cutting-edge technology in the #TechBio showcase
🔸May 4th, 14:00 – @QuinWills will be taking part in the Diversity & Inclusion in #Biotech and #Pharma panel
#TeamOchre